United States · FDA National Drug Code directory

Terbinafine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71205-152_86d7ee5e-ebfd-45ea-a520-b6f65814c3e2
Product NDC
71205-152
Form
TABLET
Composition / generic term
Terbinafine
Labeler
Proficient Rx LP
Marketing category
ANDA
Marketing start / end (source format)
20160627
Source listing expiry
20261231

Source-listed ingredients

  • TERBINAFINE HYDROCHLORIDE — 250 1/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 15 TABLET in 1 BOTTLE (71205-152-15) · 71205-152-15
  • 30 TABLET in 1 BOTTLE (71205-152-30) · 71205-152-30
  • 35 TABLET in 1 BOTTLE (71205-152-35) · 71205-152-35
  • 45 TABLET in 1 BOTTLE (71205-152-45) · 71205-152-45
  • 60 TABLET in 1 BOTTLE (71205-152-60) · 71205-152-60
  • 90 TABLET in 1 BOTTLE (71205-152-90) · 71205-152-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →